TAT-W61 peptide attenuates neuronal injury through blocking the binding of S100b to the V-domain of Rage during ischemic stroke-Reference-Cited by-同舟云学术

TAT-W61 peptide attenuates neuronal injury through blocking the binding of S100b to the V-domain of Rage during ischemic stroke

Published:2023-12-05 Issue: Volume: Page:
ISSN:0946-2716
Container-title:Journal of Molecular Medicine
language:en
Short-container-title:J Mol Med

Author:

Liang Jia,Li Hui,Liu Chang‑Dong,Zhou Xiao‑Yan,Fu Yan‑Yan,Ma Xiang-Yu,Liu Dan,Chen Yu-Ling,Feng Qian,Zhang Zhen,Wen Xiang-Ru,Zhu Guang,Wang Nan,Song Yuan-Jian

Funder

Six Talent Peaks Project in Jiangsu Province

First Affiliated Hospital of Zhengzhou University

National Natural Science Foundation of China

Natural Science Foundation of Xuzhou City

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Drug Discovery,Molecular Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00109-023-02402-8.pdf

Reference41 articles.

1. Awada Z, Abboud R, Nasr S (2019) Risk of serious bleeding with antiplatelet therapy for secondary prevention post ischemic stroke in Middle East population. Cureus 11(6):e4942

2. Fu K, Chen L, Hu S, Guo Y, Zhang W, Bai Y (2021) Grape seed proanthocyanidins attenuate apoptosis in ischemic stroke. Acta Neurol Belg 121(2):357–364

3. Holla FK, Postma TJ, Blankenstein MA, van Mierlo TJM, Vos MJ, Sizoo EM, de Groot M, Uitdehaag BMJ, Buter J, Klein M et al (2016) Prognostic value of the S100b protein in newly diagnosed and recurrent glioma patients: a serial analysis. J Neurooncol 129(3):525–532

4. Krzych ŁJ, Czempik PF, Saucha W, Kokocińska D, Knapik P (2015) Serum S100b protein concentration in brain-dead organ donors: a pilot study. Anaesthesiology intensive therapy 47(4):320–323

5. Camponeschi C, De Carluccio M, Amadio S, Clementi ME, Sampaolese B, Volonté C, Tredicine M, Romano Spica V, Di Liddo R, Ria F et al (2021) S100b protein as a therapeutic target in multiple sclerosis: the S100b inhibitor arundic acid protects from chronic experimental autoimmune encephalomyelitis. Int J Mol Sci 22(24)